WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

International application published with international search report

US10314890B2 - Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2021025177A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

US20220041712A1 - Anti-claudin 18 antibodies and methods of use thereof - Google Patents

WO2021088927A1 - Antibody-drug conjugates targeting claudin 18.2 - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

PDF) Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy

WO2019174617A1 - Anti-claudin 18.2 antibodies - Google Patents